Oregon Multistate Pharmacy Jurisprudence Examination (MPJE) Practice Exam

In Oregon, the decision to substitute a brand-name drug with a generic version is generally guided by the concept of bioequivalence, which is indicated by an AB rating. An AB rating signifies that a generic drug meets the standards for biological equivalence to the brand-name drug, ensuring that the two can be used interchangeably without compromising efficacy or safety. However, the process of generic substitution is not rigidly mandatory for pharmacists. Instead, the pharmacist has the discretion to decide whether to substitute a brand-name medication with a generic one based on several factors, including the availability of an AB-rated generic and the individual circumstances of the patient. This means that even if a generic is available, a pharmacist may choose not to substitute it if there are specific reasons not to do so, such as potential patient allergies or previous experiences with the brand-name drug. Additionally, while patients can request a specific medication, the authority for substitution ultimately lies with the pharmacist, who is tasked with ensuring that the substitution is both safe and appropriate for the patient. This reflects a balance between professional judgment and patient-centered care in the decision-making process regarding medication substitution in Oregon.